Becton Dickenson Collaborates with U.S. Government on COVID-19 Combination Testing
BARDA and Becton, Dickinson are collaborating to develop and achieve FDA 510(k) clearance on a range of combination COVID-19-related diagnostics ...
Tag: Awards
Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines
The Sabin Vaccine Institute (Sabin) announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of ...
NYMC Center of Excellence in Precision Responses to Bioterrorism and Disasters Receives $250,000 in Funding
The funding will support the Center’s emergency preparedness training and expand the facilities. New York State Assemblyman Thomas J. Abinanti ...
WSU to Lead USAID’s Global Sampling Project for Discovery of Emerging Viral Zoonoses
The USAID Discovery & Exploration of Emerging Pathogens - Viral Zoonoses (DEEP VZN) project, will build scientific capacity in partner ...
NIH RADx Initiative Funds 12 New Rapid Diagnostic Projects
The NIH Rapid Acceleration of Diagnostics (RADx) initiative announced today that it has issued contract awards totaling $77.7 million to develop and ...
UTHSC Awarded $3.2 Million for Upgrades to Regional Biocontainment Laboratory
The University of Tennessee Health Science Center has been awarded $3.2 million from the National Institute of Allergy and Infectious ...
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
The effort will leverage Partner Therapeutics’ prior experience developing Leukine for Acute Radiation Syndrome The contract award supports development of ...
Protective Biosystems: Parasites to Fight Chemical and Biological Weapons
Parasites could become part of the armour of military personnel and first responders to help them counter chemical and biological ...
Leidos Awarded DARPA Contract for Personalized Protective Biosystem Against Chemical and Biological Threats
Personalized Protective Biosystem (PPB) program aims to develop technology that reduces the need for burdensome protective equipment while increasing individual ...
Cooperative Threat Reduction: Noblis Secures $263M DTRA Support Contract
Noblis, Inc. today announced it has received a five-year, $263 million prime contract from the U.S. Department of Defense’s Defense ...
Aidar Health’s Rapid Patient Triage System Gains Federal Funding From BARDA
BARDA is collaborating with Aidar Health, Inc. to develop and validate the company’s Aidar COVID-19 decompensation index (AIDI), a new ...
BARDA-NCATS Partner with Vunjak-Novakovic Laboratory at Columbia University on Tissue-Chip Technology
BARDA's Division of Research, Innovation, and Ventures (DRIVe) and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes ...
HHS Taps Draper to Develop Lung-on-a-Chip Technology to Study SARS-CoV-2
Draper has received a $719,000 federal contract from the U.S. Department of Health and Human Services (HHS) to enhance the ...
OraSure Awarded $13.6M From BARDA to Advance COVID-19 Rapid Test
BARDA renews collaboration with OraSure Technologies to support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver BARDA and OraSure ...
Texas Biomed Scientists Partner with DoD to Test SARS-CoV-2 Decontamination Technologies
Texas Biomedical Research Institute (Texas Biomed) received two Department of Defense's (DoD) Defense Health Agency subcontracts to assess the efficacy ...
DARPA Awards Nucleic Acids On-Demand (NOW) Contract to GE Research and Collaborators
The Defense Advanced Research Projects Agency (DARPA) has awarded project funding worth up to $41 million to GE Research and a ...
UC San Diego Awarded NIH Funding for Rapid Acceleration of Diagnostics (RADx)
University of California San Diego was awarded five Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health (NIH), totaling ...
BioFactura Funded $13M Contract Option for Smallpox Biodefense Therapeutic
BioFactura, Inc. today announced a contract option activation of over $13 million by the Biomedical Advanced Research and Development Authority ...
Rigel Awarded $16.5 Million from DoD for Phase 3 Trial of Fostamatinib in COVID-19 Patients
Rigel Pharmaceuticals, Inc. announced on Jan. 29 it has been awarded $16.5 million by the U.S. Department of Defense's (DOD) Joint Program ...
Defense Threat Reduction Agency Awards $75M for Antibiotic Drug Development
In the medical and military fields, antibiotic-resistant bacteria can be formidable foes. Now, University of Florida Health researchers and their ...
